Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 295-374-7 | CAS number: 92044-94-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
The skin irritation potential of Fatty acids, lanolin, esters with cholesterol-low lanolin alcs. was assessed in vitro according to OECD Test Guideline 439. After a 65 minute exposure on the surface of the EpiDermTM reconstructed human epidermis and a 42 ± 4h post-exposure incubation time, viability of the tissues was assessed and compared to the negative control. The percentage of viability obtained was 97.710 % and therefore the substance is considered as non-irritant to the skin (XcellR8 2017).
For the hydrolysis product Lanolin fatty acids an in vivo study no irreversible signs of irritation were observed and this substance is non-irritant to the skin (Davies 1968).
The substance was tested for eye irritation in the EpiOcular TM Eye Irritation model according to OECD 492. 50 uL of the substance, positive control (methyl acetate) and negative control (H2O) was applied to the tissue for 6 hours, followed by a 25 minutes post-treatment immersion at 37°C, 5% CO2 and thereafter incubated for 18 hour post-dose at 37°C, 5% CO2 (XCellR8 2018). The substance did not interfere by colour or by direct MTT reduction. Tissue viability was 84.7% of negative controls, while validity criteria were met. The substance is concluded to be non-irritant.
In two eye irritation studies with Lanolin alcohols very limited signs of irritation to the iris were observed. The cornea and conjuctivae both produced some signs of irritation, however these values are not significant and are not enough to classify the material as an eye irritant (Davies 1968, Lewis 1977).
No signs of eye irritation were observed in a test with Lanolin alcohols in rabbits (Cade 1980)
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 17 August 2017 to 22 September 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- GLP compliance:
- yes (incl. QA statement)
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- other: Reconstructed Human Epidermis
- Cell source:
- other: MatTek kit
- Justification for test system used:
- Description EpiDermTM (EPI-200) Reconstructed Human Epidermis
Lot Number 25842
Date of Receipt 19th Sep 2017
Morphology EPI-200 LOT#: 25842
Histological examination demonstrates human epidermis-like structure: including multiple layers (at least 4) of viable epithelial cells (basal layer, stratum spinosum, stratum granulosum) which are present under multilayered stratum corneum: 9 layers--> - PASS
Tissue thickness: 95.5 µm --> Acceptance range: >70 µm and <130 µm) - PASS
Tissue Viability: Optical Density (O.D.) values: 1.39 ± 0.046 (mean and SD of MTT value of 3 tissues exposed to H2O) -->Acceptance range: [1.0 - 3.0]- PASS
Skin Barrier Function: ET 50% of tissues exposed to 100 µL Triton X-100 1% (n=3): 7.12 h -->Acceptance range: [4.77h- 8.72h] - PASS
Sterility: No evidence of contamination during long term antibiotic and antimycotic free culture: No contamination reported --> - PASS - Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: MatTek
- Tissue batch number(s): 25842
- Delivery date: 19 September 2017
- Date of initiation of testing: 25 September
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: 31 minutes at room temperature and 34 minutes at 37°C, 5% CO2, ≥95% RH
- Temperature of post-treatment incubation: 42 ± 4h post-treatment incubation
REMOVAL OF TEST MATERIAL AND CONTROLS: rinsing (no details)
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: no data
- Incubation time:no data
- Spectrophotometer: BMG LabTech FluoStar Optima (calibrated on 24 July 2017)
- Wavelength: 570 nm
- Linear OD range of spectrophotometer: not indicated
FUNCTIONAL MODEL CONDITIONS WITH REFERENCE TO HISTORICAL DATA: based on blanks obtained during 66 historical runs (no data provided)
NUMBER OF REPLICATE TISSUES: 3/treatment
PREDICTION MODEL / DECISION CRITERIA (choose relevant statement)
•A test item is considered to be an irritant (I) to skin in accordance with UN GHS Category 2 or EU R38 if the skin model viability after exposure and post-treatment incubation is ≤50%.
•A test item may be considered as a non-irritant (NI) if the skin model viability after exposure and post-treatment incubation is >50%. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- 25 mgTEST MATERIAL
- Amount(s) applied (volume or weight with unit): 25 mg neat
NEGATIVE CONTROL:Sterile Dulbecco’s Phosphate Buffered Saline (DPBS) neat
POSITIVE CONTROL: 5% Sodium dodecyl sulphate (SDS)
- Concentration (if solution): 5% in water - Duration of treatment / exposure:
- 31 minutes at room temperature and 34 minutes at 37°C, 5% CO2, ≥95% RH
- Duration of post-treatment incubation (if applicable):
- 42 ± 4h
- Number of replicates:
- 3
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 1
- Value:
- 97.7
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- Prior to the study, the required compatibility checks confirmed that the test item did not interfere with MTT and no water colouration was observed.
Acceptance criterion 1 The mean OD570 of the negative control (treated with DPBS) tissues must be ≥ 0.8 and ≤ 2.8 1.514 PASS
Acceptance criterion 2 The mean of the positive control relative percentage viability must be ≤ 20% of the mean of the negative controls. 5.097 PASS
Acceptance criterion 3 The standard deviation of viability percentages for triplicate skin models in each experimental condition must be < 18% NC: 5.243; PC: 1.176; TA2: 12.886 PASS
Acceptance criterion 4 The mean OD of the 6 wells containing extraction solvent alone (blanks) must be ≤ 0.1. 0.162 FAIL
blank controls:
Optical Density (OD) values obtained with blanks were higher than 0.1 (0.162) causing a deviation from the acceptance criteria. However, the spectrophotometer was fully validated and had passed all required tests. The OD values for blanks observed in this study are consistent with historical data using this spectrophotometer in the XCellR8 laboratory and meet our current internal acceptance criteria of blank OD values <0.194 (mean of XCellR8 historical data, based on blanks obtained during 66 historical runs), therefore this is not considered to be an issue in the interpretation of this study data. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- Based on the outcome of the study the substance is considered not irritating to the skin.
- Executive summary:
The skin irritation potential of the substance was assessed in vitro according to OECD Test Guideline 439. After exposure during 31 minutes at room temperature and 34 minutes at 37°C, 5% CO2, ≥95% RH on the surface of the EpiDermTM reconstructed human epidermis and a 42 ± 4h post-exposure incubation time, viability of the tissues was assessed and compared to the negative control. The percentage of viability obtained was 97.710 % and therefore the substance is considered as non-irritant to the skin
Reference
Viability measurements after 65 min of application and 42h (± 4h) post-incubation of test and reference items and controls.
Condition |
Tissue # |
Raw data |
Blank corrected data |
Mean OD |
% of Viability |
||
Aliquot 1 |
Aliquot 2 |
Aliquot 1 |
Aliquot 2 |
||||
NC |
Tissue 1 |
1.781 |
1.753 |
1.619 |
1.591 |
1.605 |
106.022 |
Tissue 2 |
1.657 |
1.587 |
1.495 |
1.425 |
1.460 |
96.444 |
|
Tissue 3 |
1.663 |
1.614 |
1.501 |
1.452 |
1.477 |
97.534 |
|
PC |
Tissue 1 |
0.268 |
0.251 |
0.106 |
0.089 |
0.098 |
6.451 |
Tissue 2 |
0.224 |
0.231 |
0.062 |
0.069 |
0.066 |
4.337 |
|
Tissue 3 |
0.226 |
0.234 |
0.064 |
0.072 |
0.068 |
4.502 |
|
TA2 |
Tissue 1 |
1.481 |
1.453 |
1.319 |
1.291 |
1.305 |
86.207 |
Tissue 2 |
1.657 |
1.552 |
1.495 |
1.390 |
1.443 |
95.288 |
|
Tissue 3 |
1.859 |
1.845 |
1.697 |
1.683 |
1.690 |
111.636 |
NC: negative control (DPBS), PC: Positive control (SDS 5%), TA2: test substance
Code |
Mean of OD |
SD of OD |
Mean of viability (%) |
SD of viability (%) |
CV % |
Classification |
NC |
1.514 |
0.079 |
100.000 |
5.243 |
5.243 |
Non-Irritant |
PC |
0.077 |
0.018 |
5.097 |
1.176 |
23.064 |
Irritant |
TA2 |
1.479 |
0.195 |
97.710 |
12.886 |
13.188 |
Non-Irritant |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 21 February 2018 to 01 March 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- GLP compliance:
- yes (incl. QA statement)
- Species:
- human
- Details on test animals or tissues and environmental conditions:
- - Tissue :Reconstructed human Cornea-like Epithelium (RhCE); keratincyte strain: 4F1188
- Model used: ‘EpiOcularTM irritation test ( MatTek Corporation EpiOcularTM EIT (OCL-200) Reconstituted Human Ocular Epithelium )
- Tissue batch number(s): (Lot # 27025)
- Delivery date: 25 February 2018
- Date of initiation of testing: 25 February 2018
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: 6h ± 15 minutes, followed by a 25 ± 2 minutes’ post-treatment immersion at 37°C, 5% CO2
- Temperature of post-treatment incubation: 18 hours ± 15 minutes’ post-treatment incubation at 37°C, 5% CO2
REMOVAL OF TEST MATERIAL AND CONTROLS
- Volume and number of washing steps: not indicated (according to MatTEek SOP)
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE: no data (according to MatTEek SOP)
- MTT concentration: not specified
- Incubation time: no data
- Spectrophotometer: BMG LabTech FluoStar Optima at 570 nm - Vehicle:
- unchanged (no vehicle)
- Controls:
- yes
- yes, concurrent positive control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 50 µl - Duration of treatment / exposure:
- 6h ± 15 minutes, followed by a 25 ± 2 minutes’ post-treatment immersion at 37°C, 5% CO2, 18 hours ± 15 minutes’ post-treatment incubation at 37°C, 5% CO2
- Number of animals or in vitro replicates:
- 3 replicates
- Details on study design:
- tisues were wetted with 20 uL PBS before application of the substance or controls
negative control: sterile H2O
positive control: methyl acetate (neat)
number of replicates: 3 - Irritation parameter:
- other: viability (%)
- Value:
- 84.7
- Negative controls validity:
- valid
- Remarks:
- OD570 1.902
- Positive controls validity:
- valid
- Remarks:
- viability 2.88%
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- Acceptance criteria passed
Acceptance criterion 1 The mean OD570 of the negative control(treated with PBS) tissues is > 0.8 and < 2.8
Acceptance criterion 2 The mean of the positive control relative percentage viability must be below 50% of the mean of the negative controls.
Acceptance criterion 3 The standard deviationof OD values between three replicates in each experimental condition must be ≤ 18%
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The substance is not irritant when tested in the EpiOcular TM Eye Irritation Test
- Executive summary:
The substance was tested for eye irritation in the EpiOcular TM Eye Irritation model according to OECD 492. 50 uL of the substance, positive control (methyl acetate) and negative control (H2O) was applied to the tissue for 6 hours, followed by a 25 minutes post-treatment immersion at 37°C, 5% CO2 and thereafter incubated for 18 hour post-dose at 37°C, 5% CO2.
The substance did not interfere by colour or by direct MTT reduction. Tissue viability was 84.7% of negative controls, while validity criteria were met. The substance is concluded to be non-irritant.
Reference
Name |
Code |
Mean of OD |
SD of OD |
Mean of viability (%) |
SD of viability (%) |
CV % |
Classification |
Sterile water |
NC |
1.902 |
0.090 |
100.000 |
4.75 |
4.745 |
No Category |
Methyl Acetate |
PC |
0.055 |
0.049 |
2.882 |
2.569 |
89.140 |
No Prediction |
Test substance-SO-(RB) |
TA2 |
1.611 |
0.090 |
84.685 |
4.748 |
5.607 |
No Category |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
Based on the information available, the substance does not need to be classified for skin- and eye-irritation according to Regulation (EC) No 1272/2008 (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.